Indoleacrylic acid
|
Basic information |
| Metabolite name | Indoleacrylic acid |
 | HMDB0000734 |
 |
N/A |
 |
15030923 |
| Synonyms | Trans-3-indoleacrylic acid; |
| No. of studies | 13 |
|
Basic information |
| Metabolite name | Indoleacrylic acid |
| HMDB0000734 |
|
N/A |
|
15030923 |
| Synonyms | Trans-3-indoleacrylic acid; |
| No. of studies | 13 |
|
Relationship between Indoleacrylic acid and depression (count: 13) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M048 | Type1 | CVS group vs. control group | Hippocampus | Wistar rat | Down |
| Study M048 | Type2 | CVS + CSGS group vs. CVS group | Hippocampus | Wistar rat | Up |
| Study M048 | Type2 | CVS + fluoxetine group vs. CVS group | Hippocampus | Wistar rat | Up |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M076 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M076 | Type2 | CUMS + Anemarrhena saponins and Lilium saponins group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M076 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M099 | Type3 | probiotics group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M099 | Type3 | high-fat diet + probiotics group vs. high-fat diet grou | Plasma | Sprague-Dawley rat | Up |
| Study M104 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M104 | Type2 | CUMS + BH group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M104 | Type2 | CUMS + fluoxetine group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M104 | Type2 | CUMS + ZB group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M1093 | Type1 | CSDS group vs. control group | Serum | C57BL/6N mouse | Up |
| Study M116 | Type3 | LY group vs. control group | Cerebrospinal fluid | Sprague-Dawley rat | Down |
| Study M454 | Type1 | vascular depression model group vs. control group | Hippocampus | ICR mouse | Down |
| Study M454 | Type2 | vascular depression model + YXST group vs. vascular depression model group | Hippocampus | ICR mouse | Up |
| Study M541 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M541 | Type2 | CUMS + venlafaxine group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M613 | Type2 | CSDS susceptible + imipramine group vs. CSDS + vehicle group | Serum | C57BL/6 J mouse | Down |
| Study M619 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M619 | Type2 | CUMS + middle dose of Jiaotaiwan group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M619 | Type2 | CUMS + low dose of Jiaotaiwan group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M924 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M924 | Type2 | CUMS + aerobic exercise group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M956 | Type1 | CUMS group vs. control group | Faece | C57BL/6J mouse | Down |